Abstract
The potential use of the peritoneum as a dialyzing membrane was recognized as early as 1923 (1,2). Nevertheless, not until a permanent indwelling peritoneal catheter was developed in 1964 by Palmer et al. (3) and later modified by Tenckhoff (4) did long-term intermittent peritoneal dialysis (IPD) become a practical alternative to hemodialysis. However, probably mainly due to inadequate dialysis, the cumulative technique survival on IPD was low (5), and hemodialysis remained the predominant form of dialysis therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Putnam J: The living peritoneum as a dialyzing membrane. Am J Physiol 63: 548–565, 1923.
Ganter G: Uber die beseitigung gigtiger stoffe dein blute durch dialyse. Munch Med Wochenschr 70: 1478–1480, 1923.
Palmer RA, Quinton WE, Gray JF: Prolonged peritoneal dialysis for renalfailure. Lancet 1: 700–702, 1964.
Tenckhoff H, Schechter H: A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14: 181–186, 1968.
Ahmad S, Gallagher N, Shen F: Intermittent peritoneal dialysis: status reassessed. Trans Am Soc Artif Intern Organs 25: 86–88, 1979.
Popovich RP, Moncrief JW, Decherd JF, et al.: The definition of a novel portable/wearable equilibrium dialysis technique. Trans Am Soc Artif Intern Organs 5: 64A, 1976.
Popovich RP, Moncrief JW, Nolph KD, et al.: Continuous ambulatory peritoneal dialysis. Ann Intern Med 88:449 -156, 1978.
Oreopoulos DG, Robson M, Izatt S, et al.: A simple and safe technique for continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 24: 484–489, 1978.
Gokal R: World-wide experience, cost effectiveness and future of CAPD—its role in renal replacement therapy. In: R Gokal, ed, Continuous Ambulatory Peritoneal Dialysis. Churchill Livingstone, Edinburgh, pp 349–369, 1986.
1993 World-wide Registry Update. Baxter Healthcare, Deerfield, IL, 1993.
Nolph KD, Popovich RP, Moncrief JW: Theoretical and practical implications of continuous ambulatory peritoneal dialysis. Nephron 21: 117–122, 1978.
Bergstrom J, Asaba H, Furst P, ct al: Middle molecules in chronic uremic patients treated with continuous ambulatory peritoneal dialyis. Perit Dial Bull 3: S7 - S9, 1983.
Nolph KD, Sorkin M, Rubin J, et al: Continuous ambulatory peritoneal dialysis: three-year experience at one center. Ann Intern Med 92: 609–613, 1980.
Zappacosta AR, Caro J, Erslev A: Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. The role of erythropoietin. Am J Med 72: 53–57, 1982.
De Paepe MBJ, Schelstraete KGH, Ringoir SMG, et al: Influence of continuous ambulatory peritoneal dialysis on the anemia of end-stage renal disease. Kidney Int 27: 744–748, 1983.
Sunderrajan S, Nolph KD: Longitudinal study of nerve conduction velocities during continuous ambulatory peritoneal dialysis. Pent Dial Bull 5: 48–50, 1985.
Kim D, Blair G, Wu G, et al.: Electrophysiological studies of nerve function in patients on CAPD over long periods. Perit Dial Bull 5: 45–48, 1985.
Rottembourg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 43 (Suppl 40): S106 - A110, 1993.
Levery AS, Harrington JT: Continuous peritoneal dialysis for chronic renal failure. Medicine (Baltimore) 61: 330–339, 1982.
Gokal R, Marsh F: Survey of CAPD in UK-1982. Perit Dial Bull 4: 240–243, 1984.
Nichols AJ, Waldek S, Plats MM, et al: Impact of CAPD on treatment of renal failure in patients over 60. Br Med J 288: 18–19, 1984.
Fine RN: Peritoneal dialsis update. J Pediatr 100: 1–7, 1982.
Rubin J, Bell R: Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Arch Intern Med 146: 1533–2538, 1986.
Amair P, Khanna R, Leibel B, et al: Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. N Engl J Med 306: 625–630, 1982.
Khanna R: Dialysis considerations for diabetic patients. Kidney Int 43 (Suppl 40): S58 - S64, 1993.
Flynn CT, Nanson JA: Intraperitoneal insulin with CAPD— an artifical pancreas. Trans Am Soc Artif Intern Organs 25: 114–117, 1979.
Madden MA, Zimmerman SW, Simpson DP: CAPD in diabetes mellitus—the risks and benefits of intraperitoneal insulin. Am J Nephrol 2: 133–139, 1982.
Gokal R, Ramos JM, Veitch P, et al.: Renal transplantation in patients on continuous ambulatory peritoneal dialysis. Proc Eur Dial Tranplant Assoc 18: 222–227, 1981.
Stephanidis CJ, Balfe JW, Arbus GS, et al.: Renal translantation in children treated with continuous ambulatory peritoneal dialysis. Perit Dial Bull 3: 5–8, 1983.
Moncrief JW, Sorrels PAJ, Druger VG, et al: Development of training programs for continuous ambulatory peritoneal dialysis—historical review. In: M Legrain, ed, Continuous Ambulatory Peritoneal Dialysis. Excerpta Medica, Amsterdam, pp 149–151, 1980.
Oreopoulos DG: Requirements for the organisation of a CAPD Program. Nephron 24: 261–263, 1979.
Moon J, Uttley L, Mano J, et al.: Home CAPD nurse, an asset to a CAPD programme? In: JF Maher, JF Winchester, eds, Frontiers in Peritoneal Dialysis. Field Rich and Associates, New York, pp 360–363, 1986.
Nolph KD, Twardowski ZJ, Popovich RP, et al.: Equilibration of peritoneal dialysis solutions during long dwell exchanges. J Lab Clin Med 93: 246–256, 1979.
Nolph KD, Popovich RP, Ghods AJ, et al.: Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 13: 117–123, 1978.
Twardowski ZJ: Individualized dialysis for CAPD patients. Uremia Invest 8: 35–43, 1984.
Henderson LW: Peritoneal ultrafiltration dialysis: enhanced urea transfer using hypertonic peritoneal dialysis fluid. J Clin Invest 45: 950–955, 1966.
Henderson LW, Nolph KD: Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid. J Clin Invest 48: 992–1001, 1983.
Twardowski ZJ, Prowant B, Nolph KD, et al.: High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 23: 64–70, 1983.
Keshaviah P: Adequacy of PD: a quantitative approach. Kidney Int 42 (Suppl 32): S160 - S164, 1992.
Lindsay RM, Spanner E, Heidenheim RP, LeFebvre JM, Hodsman A, Baird J, Allison MEM: Which comes first, KT/ V or PCR—chicken or egg? Kidney Int 42 (Suppl 38):S32- S36, 1992.
Nolph KD: Small solute clearances and clinical outcomes in CAPD. Perit Dial Int 12: 343–345, 1992.
Khanna R, Nolph KD: Ultrafiltration failure and sclerosing peritonitis in peritoneal dialysis patients. In: AR Nissenson, RN Fine, eds, Dialysis Therapy. Hanley and Belfus, Philadelphia, pp 122–125, 1986.
Twardowski ZJ, Nolph KD, Khanna R, et al: Peritoneal equilibration test. Perit Dial Bull 7: 138–147, 1987.
Werger C, Larpent L, Dumontet M: Prognostic value of peritoneal equilibration curves in CAPD patients. In: JF Maher, JF Winchester, eds, Frontiers in Peritoneal Dialysis. Field, Rich and Associates, New York, pp 88–93, 1986.
Nolph KD, Miller FN, Pyle WK, et al: An hypothesis to explain the ultrafiltration characterisitics of peritoneal dialysis. Kidney Int 20: 543–548, 1981.
Mactier RA, Khanna R, Twardowski Z, et al.: Role of peritoneal cavity lymphatic absorption in peritoneal dialysis. Kidney Int, in press.
Mactier RA, Khanna R, Twardowski Z, et al.: Lymphatic absorption in CAPD. Kidney Int 31: 252A, 1987.
Twardowski ZJ, Khanna R, Nolph KD: Osmotic agents and ultrafiltration in peritoneal dialysis. Nephron 42: 93–101, 1986.
Rottembourg J, El shahat Y, Agrafiotis A, et al.: Continuous ambulatory perioneal dialysis in insulin-dependent diabetic patients. A 40-month experience. Kidney Int 23: 40–45, 1983.
Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. Nephron 33:133–138
Faller B, Marichal JF: Loss of ultrafiltration in continuous ambulatory peritoneal dialysis: a role for acetate. Perit Dial Bull 4: 10–13, 1984.
Twardowski ZJ, Tully RJ, Nichols WK, et al.: Computerized tomography in the diagnosis of subcutaneous leak sites during CAPD. Perit Dial Bull 4: 163–166, 1984.
Wideroe TE, Smeby LC, Mjaaland S, et al.: Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis. Nephron 38:238–247
Mactier RA, Khannna R, Twardowski Z, et al.: Ultrafiltration failure in CAPD due to excessive peritoneal cavity lymphatic absorption. Am J Kidney Dis, in press.
Pyle WK, Popovich RP, Moncrief JW: Mass transfer evaluation in peritoneal dialysis. In: JW Moncrief, RP Popovich, eds, CAPD Update. Masson, New York, pp 35–52, 1981.
Twardowski Z, Ksiazek A, Majdan M, et al: Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day. Clin Nephrol 15: 119–130, 1981.
Leenen FHH, Shah P, Boer WH, et al: Hypotension in CAPD: an approach to treatment. Perit Dial Bull 3: S33 - S35, 1983.
Young MA, Nolph KD, Dutton S, et al.: Anti-hypertensive drug requirements in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 85–88, 1984.
Glasson PH, Favre H, Valloton MB: Response of blood pressure and the renin-angiotensin-aldosterone system to chronic ambulatory peritoneal dialysis in hypertensive end-stage renal failure. Clin Sci 63: S207–209, 1982.
Nolph KD, Hano JE, Teschan PE: Peritoneal sodium transport during hypertonic peritoneal dialysis: physiologic mechanisms and clinical implications. Ann Intern Med 70: 931–941, 1969.
Nolph KD, Sorkin MI, Moore H: Autoregulation of sodium and potassium removal during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 6: 334–337, 1980.
Marquez-Julio A, Dombros N, Osmond D, et al.: Hypotension in patients on continuous ambulatory peritoneal dialysis. In: M Legrain, ed, Proceedings of the First International Symposium on CAPD. Excerpta Medica, Amsterdam, pp 263–267, 1979.
Nolph KD, Prowant B, Serkes KD, et al.: Multicenter evaluation of a new peritoneal dialysis solution with a high lactate and a low magnesium concentration. Perit Dial Bull 3: 63–65, 1983.
An International Cooperative Study (Third Report): A survey of ultrafiltration in CAPD. In: R Khanna, KD Nolph, B Prowant, ZJ Twardowski, DG Oreopoulos, eds, Advances in Continuous Ambulatory Peritoneal Dialysis. University of Toronto Press, Toronto, pp 79–86, 1985.
Gandhi VC, Humayun HM, Ing TS, et al.: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140: 1201–1203, 1980.
Novello AC, Port FK: Sclerosing encapsulating peritonitis. Int J Artif Organs 9: 393–396, 1986.
Feriani M, Biasioli S, Boring D, et al.: Bicarbonate buffer for CAPD solutions. Trans Am Soc Artif Organs 31: 668–672, 1985.
Blumenkrantz MJ, Kopple JD, Mora JK, et al: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21: 849–861, 1982.
Delmez JA, Slatopolsky E, Martin KJ, et al.: Minerals, vitamin D, and parathyroid hormone in CAPD. Kidney Int 21: 862–867, 1982.
Parker A, Nolph KD: Magnesium and calcium transfer during CAPD. Trans Am Soc Artif Intern Organs 26: 194–196, 1980.
Cassidy MJD, Owen JP, Ellis HA, et al: Renal osteodystrophy and metastatic calcification in long-term CAPD. Q J Med 213: 29–48, 1985.
Davenport A, Goel S, Mackenzie JC: Audit of the use of calcium carbonate as a phosphate binder in 100 patients treated with continuous ambulatory peritoneal dialysis.
Nephrol Dial Transplant 7:632–635,1992.
Hutchison AJ, Freemont AJ, Boulton HF, Gokal R: Low-calcium dialysis fluid and oral calcium carbonate in CAPD: a method of controlling hyperphosphatemia whilst minimizing aluminum exposure and hypercalcemia. Nephrol Dial Transplant 7: 1219–1225, 1992.
Slatopolsky E, Weerts C, Lopez-Hilder S, et al.: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315: 157–161, 1986.
Mactier RA, Nolph KD, Khanna R, et al: Risk factors for hyperaluminemia in continuous ambulatory peritoneal dialysis. Perit Dial Bull 6: 188–193, 1986.
Salusky IB, Coburn JB, Paunier L, et al.: Role of aluminum hydroxide in raising serum aluminum levels in children undergoing CAPD. J Pediatr 105: 717–720, 1984.
Rottembourg J, Gallego JL, Jaudon M, et al.: Serum concentration and peritoneal mass transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis. Kidney Int 24: 99–924, 1984.
Sorkin MI, Nolph KD, Anderson HO, et al.: Aluminum mass transfer during continuous ambulatory peritoneal dialysis. Perit Dial Bull 1: 91–94, 1981.
Bertholf RL, Roman, JM, Brown S, et al.: Aluminum hydroxide induced osteomalacia, encephalopathy and hyperaluminemia in CAPD, treatment with desferrioxamine. Perit Dial Bull 4: 30–32, 1984.
Cumming AD, Simpson G, Bell D, et al.: Acute aluminum intoxication in patients on continuous ambulatory peritoneal dialysis. Lancet 1: 103–104, 1982.
Guillot AP, Hood BL, Runge CF, et al.: Use of magnesium containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis. Nephron 30: 114–117, 1982.
Nolph KD, Ryan L, Prowant B, et al.: A cross-sectional assessment of serum vitamin D and triglyceride concentration in a CAPD population. Perit Dial Bull 4: 232–237, 1984.
Gokal R, Ramos JM, Ellis HA, et al.: Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. Kidney Int 23: 15–21, 1983.
Aloni Y, Shany S, Chaimovitz C: Losses of 25-hydroxy vitamin D in peritoneal fluid: possible mechanisms for bone disease in uremic patients treated with CAPD. Miner Electrolyte Metab 9: 82–86, 1983.
Delmez J A: Calcitriol and secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 13: 95–97, 1993.
Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int 43: 436–442, 1993.
Kopple JD, Blumenkrnatz MJ: Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 24: S295 - S302, 1983.
Dulaney JT, Hatch FE: Peritoneal dialysis and loss of proteins: a review. Kidney Int 26: 253–262, 1984.
Rubin J, Nolph KD, Arfania D, et al: Protein losses in continuous ambulatory peritoneal dialysis. Nephron 28: 218–221, 1981.
Blumenkrantz MJ, Gahl GM, Kopple JD, et al: Protein losses during peritoneal dialysis. Kidney Int 19: 593–602, 1981.
Rubin J, Ray R, Barnes T, et al.: Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 29: 124–127, 1981.
Krediet RT, Zuyderhoudt FMJ, Boeschoten EW, et al.: Alterations in peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest, in press.
Dombros N, Oren A, Marliss EB, et al.: Plasma amino acid profiles and amino acid losses in patients undergoing CAPD. Perit Dial Bull 2: 27–32, 1982.
Giordano C, De Santo NG, Capodicasa G, et al.: Amino acid losses during CAPD. Clin Nephrol 14: 230–232, 1980.
Kopple JD, Blumenkrantz MJ, Jones MR, et al.: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36:395–402
Lindhom B, Bergstrom J: Nutritional aspects on peritoneal dialysis. Kidney Int 42 (Suppl 38):S165–S171
Bergstrom J, Lindhom B: Nutrition and adequacy of dialysis: how do hemodialysis and CAPD compare? Kidney Int 43 (Suppl 40): S39 - S50, 1993.
Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albumin in patients on continuous ambulatory peritoneal dialysis: predictors and correlations with outcomes. J Am Soc Nephrol 3: 1501–1507, 1993.
Zaltzman JS, Fenton SSA: Continuous ambulatory peritoneal dialysis and nutritional adequacy. Semin Dial 5: 257–260, 1992.
Blumberg A, Hanck A, Sander G: Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 20: 244–250, 1983.
Henderson IS, Leung ACT, Shenkin A: Vitamin status in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 143–145, 1984.
Grodstein GP, Blumenkrantz MJ, Kopple JD, et al: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19: 564–567, 1981.
Von Baeyer H, Gahl GM, Riedinger H, et al.: Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 23: 29–34, 1983.
Young GA, Hobson SM, Young SM, et al.: Adverse effects of hypertonic dialysis fluid during CAPD. Lancet 2:1421
Cattran DC, Steiner GS, Fenton SSA, et al.: Dialysis hyperlipemia: response to dietary manipulations. Clin Nephrol 13: 177–182, 1980.
Ramos JM, Heaton A, Mc Gurk JC, et al.: Sequential changes in serum lipids and their subtractions in patients receiving continuous ambulatory peritoneal dialysis. Nephron 35: 20–23, 1983.
Giordano C, De Santo NG, Pluvio M, et al: Protein requirement of patients on CAPD: a study of nitrogen balance. Int J Artif Organs 3: 11–14, 1980.
Thomson NM, Stenens BJ, Humphery TJ, et al.: Comparison of trace elements in peritoneal dialysis, hemodialysis and uremia. Kidney Int 23: 9–14, 1983.
Keane WF, Peterson PK: Host defense mechanisms of the peritoneal cavity and continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 122–127, 1984.
Deane WF, Comty CM, Verbrugh HA, et al.: Opsonic deficiency of peritoneal dialysis effluent in contiuous ambulatory peritoneal dialysis. Kidney Int 25: 539–543, 1984.
Verbrugh HA, Keane WF, Hoikal JR, et al.: Peritoneal macrophage and opsonins: antibacterial defense in patients on chronic peritoneal dialysis. J Infect Dis 147: 1018–1029, 1983.
Duwe AK, Vas SI, Weatherhead JW: Effect of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect lmmun 33: 130–135, 1981.
Lamperi S, Carozzi S: Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis. Perit Dial Bull 6: 87–92, 1986.
Khanna, R, Nolph KD, Prowant BF, Twardowski ZJ: Computer interactive session: peritonitis. In: R Khanna, ed, Advances in Peritoneal Dialysis. Peritoneal Publications, Toronto, in press.
Chan MK, Biallod RA, Tanner A, et al: Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J 283: 826. 1981.
Rubin J, Raju S, Teal N, et al.: Abdominal hernia in patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med 142: 1453–1455, 1982.
Digenis GE, Khanna R, Mathews R, et al.: Abdominal hernia in patients undergoing CAPD. Perit Dial Bull 2: 115–118, 1982.
Helfrich GB, Pechan BW, Alifani MR, et al.: Reduced catheter complications with lateral placement. Perit Dial Bull 3: S2 - S4, 1983.
Khanna R, Oreopoulos DG: Peritoneal access using the Toronto Western Hospital permanent catheter. Perspect Perit Dial 1: 4–6, 1983.
Cooper JC, Nicholls AJ, Simms AG, et al.: Genital edema in patients treated by continuous ambulatory peritoneal dialysis: an unusual presentation of inguinal hernia. Br Med J 286: 1923–1924, 1983.
Singh S, Vaidya P, Dale A, et al.: Massive hydrothorax complicating continuous ambulatory peritoneal dialysis. Nephron 34: 168–172, 1983.
Grefberg N, Danielson BG, Benson L, et al: Right-sided hydrothorax complicating peritoneal dialysis. Nephron 34: 130–134, 1983.
Spadaro JJ, Thakur V, Nolh KD: Technetium-99m-labelled macroaggragated albumin in demonstration of transdiaphragmatic leakage of dialysate in peritoneal dialysis. Am J Nephrol 2: 36–38, 1982.
Rudnick MR, Coyle JF, Beck LH, et al.: Acute massive hydrothorax complicating peritoneal dialysis, report of 2 cases and review of the literature. Clin Nephrol 12: 38–44, 1979.
Twardowski ZJ, Khanna R, Nolph KD, et al: Intraabdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis. Nephron 44: 129–135, 1986.
Epstein SW, Inouye T, Robson M, et al.: Effect of peritoneal dialysis fluid on ventilatory function. Perit Dial Bull 2: 120–122, 1982.
Franklin JO, Alpert MA, Twardowski ZJ, et al: Effect of intraperitoneal infusion volume and posture on left ventricular systolic junction in patients on continuous ambulatory peritoneal dialysis. J Am Soc Artif Intern Organs 15: 49A, 1986.
Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic studies on human mesothelial cells in vitro. Kidney Int 41: 1280–1285, 1992.
Martison E, Weislander A, Kjellstrand P, Boberg U: Toxicity
of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 38: M370 - M372, 1993.
De Fijter CWH, Verbrugh HA, Oe LP, Heezius E, Donker AJM, Verhoef J, Gokal R: Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 21: 411–418, 1993.
Gokal R, Ramos JM, Francis DMA, et al.: Peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2:1388— 1391, 1982.
Spencer PC, Farrell PC: Solute and water kinetics in CAPD. In: R Gokal, ed, Continuous Ambulatory Peritoneal Dialysis. Churchill Livingstone, Edinburgh, pp 38–55, 1986.
Gilmour J, Wu G, Khanna R, et al.: Long-term continuous ambulatory peritoneal dialysis. Perit Dial Bull 5: 112–118, 1985.
Khanna R, Mcneely DJ, Oreopoulos DG, et al.: Treating fungal infections: fungal peritonitis in CAPD. Br Med J 280: 1147–1148, 1980.
Miller FN, Nolph Kd, Joshua IG, Weigman DL, Harris PD, Anderson DB: Hyperosmolality, acetate and lactate: dilatory factors during peritoneal dialysis. Kidney Int 20:397 -102, 1981.
Slingeneyer A, Faller B, Beraud JT: Progressive sclerosing peritonitis: late and severe complication of maintenance peritoneal dialysis. Tran Am Soc Artif Intern Organs 29: 633–638, 1983.
Rottembourg J, Gahl GM, Piognet JL, et al.: Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 20: 236–241, 1983.
Bradley JA, Mcwhinnie DL, Hamiton DNH, et al: Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis. Lancet 2: 113–114, 1983.
Slingeneyer A, Ellie M: Co-operative international study on sclerosing encapsulating peritonitis: preliminary report. In: R Khanna, KD Nolph, B Prowant, et al, eds, Advances in Continuous Ambulatory Peritoneal Dialysis. University of Toronto Press, Toronto, pp 118–123, 1985.
Junor BJR, Briggs JD, Forwell MA, et al.: Sclerosing peritonitis: Role of chlorhexedine in alcohol. Perit Dial Bull 5: 101–104, 1985.
Verger C, Brunschvicg O, Le Carpentier Y, et al: Structural and ultrastructural peritoneal membrane changes and permeability alterations during CAPD. Proc Eur Dial Transplant Assoc 18: 199–203, 1981.
Gahl GM, Von Baeyer H, Averdunk R, et al.: Outpatient evaluation of dietary intake and nitrogen removal in continuous ambulatory peritoneal dialysis. Ann Intern Med 94: 643–646, 1981.
Blumenkrantz MJ, Kopple JD, Moran JK, et al.: Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 20: 78–82, 1981.
Williams P, Marliss E, Anderson GH, et al.: Amino acid absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull 3: 66–73, 1982.
Oren A, Wu G, Anderson GH, et al.: Effective use of amino acid dialysate over 4 weeks in CAPD patients. Perit Dial Bull 3: 66–73, 1983.
Chan MK, Varghese Z, Moorhead JF: Lipid abnormalities in ureamia, dialysis and transplantation. Kidney Int 19: 625–637, 1981.
Avram MM, Golwasser P, Burrel DE, Antignani A, Fein PA, Mittman N: The uremic dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis 20: 324–335, 1992.
Kandoussi A, Cachera C, Pagniez D, Fruchart JC, Tacquet A: Apo AIV in plasma and dialysate fluid of CAPD patients: comparison with other apolipoproteins. Nephrol Dial Transplant 7: 1026–1029, 1992.
Heaton A, Johnston DG, Burrin JM, et al: Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single cycle. Clin Sei 65: 539–545, 1983.
Williams P, Kay R, Harrison J, et al.: Nutritional and anthropometric assessment of patient on CAPD over 1 year: contrasting changes in total body nitrogen and potassium. Perit Dial Bull 1: 82–87, 1981.
Rubin J, Flynn MA, Nolph KD: Total body potassium—a guide to nutritional health in patients undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 34: 94–98, 1981.
Rubin J, Kirchner K, Barnes T, et al.: Evaluation of continuous ambulatory peritoneal dialysis. Am J Kidney Dis 3: 199–204, 1983.
Turgan C, Feehally J, Bennett S, et al.: Accelerated hypertriglyceridemia in patients on continuous ambulatory peritoneal dialysis—a preventable abnormality. Int J Artif Organs 4: 158–160, 1981.
Wu G: Osmotic agents for peritoneal dialysis solution. Perit Dial Bull 2: 151–154, 1982.
Wanner C, Lubrich-Birkner I, Summ O, Wieland H, Schollmeyer P: Effect of simvastatin on qualitative changes of lipoprotein metabolism in CAPD patients. Nephron 62: 40–46, 1992.
Elisaf MS, Dardamanis MA, Papagalanis ND, Siamopoulos KC: Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil. Perit Dial Int 13:101— 108, 1993.
Canadian Renal Failure Register: Kidney Foundation of Canada-1986 Report. 1987.
Wing AJ, Broyer M, Brunner FP, et al.: Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 20: 2–75, 1983.
Hutchison TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease: an age equivalent index. Ann Intern Med 96:417 -123,1982.
Nelson CB, Port FK, Wolfe RA, Guire KE: Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 3: 1147–1155, 1992.
Maiorca R, Cancarini GC, Brunori G, Camarini C, Manili L: Morbidity and mortality of CAPD and hemodialysis. Kidney Int 43 (Suppl 40): S4 - S15, 1993.
Winchester JF, Rotellar C, Goggins M, Robino D, Alijani MR, Rokowski TA, Argy WP: Transplantation in peritoneal dialysis and hemodialysis. Kidney Int 43 (Suppl 40):S101- S105, 1993.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Khanna, R., Mactier, R., Nolph, K.D. (1998). Continuous Ambulatory Peritoneal Dialysis. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_56
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6632-5_56
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6634-9
Online ISBN: 978-1-4757-6632-5
eBook Packages: Springer Book Archive